249 related articles for article (PubMed ID: 29470775)
1. Influence of body mass index in anti-Müllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit.
Simões-Pereira J; Nunes J; Aguiar A; Sousa S; Rodrigues C; Sampaio Matias J; Calhaz-Jorge C
Endocrine; 2018 Jul; 61(1):144-148. PubMed ID: 29470775
[TBL] [Abstract][Full Text] [Related]
2. Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.
Moy V; Jindal S; Lieman H; Buyuk E
J Assist Reprod Genet; 2015 Sep; 32(9):1305-11. PubMed ID: 26194744
[TBL] [Abstract][Full Text] [Related]
3. The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients.
Albu D; Albu A
Endocrine; 2019 Jan; 63(1):157-163. PubMed ID: 30238328
[TBL] [Abstract][Full Text] [Related]
4. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
5. Increased body mass index is negatively associated with ovarian reserve as measured by anti-Müllerian hormone in patients with polycystic ovarian syndrome.
Kloos J; Perez J; Weinerman R
Clin Obes; 2024 Jun; 14(3):e12638. PubMed ID: 38156530
[TBL] [Abstract][Full Text] [Related]
6. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.
Vagios S; James KE; Sacha CR; Hsu JY; Dimitriadis I; Bormann CL; Souter I
Fertil Steril; 2021 Jan; 115(1):229-237. PubMed ID: 33077236
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
Pearce K; Gleeson K; Tremellen K
Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912
[TBL] [Abstract][Full Text] [Related]
9. Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome.
Kriseman M; Mills C; Kovanci E; Sangi-Haghpeykar H; Gibbons W
J Assist Reprod Genet; 2015 Sep; 32(9):1313-6. PubMed ID: 26238387
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Broer SL; Broekmans FJ; Laven JS; Fauser BC
Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
[TBL] [Abstract][Full Text] [Related]
11. Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome.
Chiofalo F; Ciuoli C; Formichi C; Selmi F; Forleo R; Neri O; Vuolo G; Paffetti P; Pacini F
Obes Surg; 2017 Jul; 27(7):1750-1754. PubMed ID: 28378209
[TBL] [Abstract][Full Text] [Related]
12. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis.
Moslehi N; Shab-Bidar S; Ramezani Tehrani F; Mirmiran P; Azizi F
Menopause; 2018 Sep; 25(9):1046-1055. PubMed ID: 29738413
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index.
Rios JS; Greenwood EA; Pavone MEG; Cedars MI; Legro RS; Diamond MP; Santoro N; Sun F; Robinson RD; Christman G; Zhang H; Huddleston HG
J Clin Endocrinol Metab; 2020 Jan; 105(1):e555-63. PubMed ID: 31586179
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the association between modifiable lifestyle factors and circulating anti-Müllerian hormone.
Werner L; van der Schouw YT; de Kat AC
Hum Reprod Update; 2024 May; 30(3):262-308. PubMed ID: 38402486
[TBL] [Abstract][Full Text] [Related]
17. The impact of repetitive oocyte retrieval on the ovarian reserve: a retrospective cohort study.
Marschalek J; Ott J; Aitzetmueller M; Mayrhofer D; Weghofer A; Nouri K; Walch K
Arch Gynecol Obstet; 2019 May; 299(5):1495-1500. PubMed ID: 30790103
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-müllerian hormone concentrations in reproductive age women with and without polycystic ovary syndrome: the influence of body mass index.
Sahmay S; Guralp O; Senturk LM; Imamoglu M; Kucuk M; Irez T
Reprod Med Biol; 2011 Jun; 10(2):113-120. PubMed ID: 29699087
[TBL] [Abstract][Full Text] [Related]
19. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
20. Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries.
Lefebvre T; Dumont A; Pigny P; Dewailly D
Reprod Biomed Online; 2017 Sep; 35(3):325-330. PubMed ID: 28624344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
